histogen


Also found in: Medical, Encyclopedia.

histogen

(ˈhɪstəˌdʒɛn)
n
(Botany) (formerly) any of three layers in an apical meristem that were thought to give rise to the different parts of the plant: the apical meristem is now regarded as comprising two layers. See corpus, tunica
Collins English Dictionary – Complete and Unabridged, 12th Edition 2014 © HarperCollins Publishers 1991, 1994, 1998, 2000, 2003, 2006, 2007, 2009, 2011, 2014

his•to•gen

(ˈhɪs tə dʒən, -ˌdʒɛn)

n.
a region in a plant in which tissues differentiate.
[1920–25]
Random House Kernerman Webster's College Dictionary, © 2010 K Dictionaries Ltd. Copyright 2005, 1997, 1991 by Random House, Inc. All rights reserved.
Mentioned in ?
References in periodicals archive ?
The players covered in the report include Kerastem, Eclipse, Regen Lab SA, Stem cell Technologies, Inc., RepliCel Life Sciences, Histogen, Inc., and Glofinn Oy.
SAN DIEGO, Calif., May 3, 2018 -- The FDA has approved Histogen, Inc.'s Investigational New Drug (IND) application to study a product treating female diffuse hair loss.
Regenerative medicine company Histogen Inc reported on Thursday the receipt of approval of its Investigational New Drug (IND) application from the US Food and Drug Administration (FDA) to study its lead product Hair Stimulating Complex (HSC660) in female diffuse hair loss.
The judging panel was led by former Broadcom chairman John Major and Histogen founder and CEO Gail Naughton, and included representatives from UCSD's Rady School of Management, CSU San Marcos' School of Business and the La Jolla Institute, as well as several entrepreneurs who have successfully navigated the M&A process.
* JAPAN: Histogen Aesthetics has entered into a licensing and distribution agreement with JPGH Co., Ltd.
With the trend toward avoiding the knife and treating skin on a cellular level, Histogen Aesthetics, a subsidiary of regenerative medicine company Histogen, Inc., focused on skin care and cosmeceuticals, has acquired the CellCeuticals Biomedical Skin Treatments line of skin care products.
US Stratus Media Group Inc (OTCBB:SMDI) said it had inked a letter of intent (LoI) to buy regenerative medicine company Histogen Inc for an undisclosed sum.
The players covered in the report include Kerastem, Eclipse, Regen Lab SA, Stemcell Technologies, Inc., RepliCel Life Sciences, Histogen, Inc., and Glofinn Oy.